Association between biomarkers of ovarian reserve and infertility among older women of reproductive age

JAMA - Journal of the American Medical Association

Volumn 318, Issue 14, 2017, Pages 1367-1376

  Steiner, Anne Z ^a   Pritchard, David ^b   Stanczyk, Frank Z ^c   Kesner, James S ^d   Meadows, Juliana W ^d   Herring, Amy H ^e   Baird, Donna D ^f  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b University of North Carolina at Chapel Hill   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^e Duke University   (United States)

^f NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; INHIBIN B; MUELLERIAN INHIBITING FACTOR; BIOLOGICAL MARKER; INHIBIN;

ADULT; AGE; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; BODY MASS; CAUCASIAN; COHORT ANALYSIS; FEMALE; FEMALE INFERTILITY; FOLLOW UP; HAZARD RATIO; HORMONAL CONTRACEPTION; HUMAN; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; OBESITY; OVARIAN RESERVE; PREDICTION; PREGNANCY; PREGNANCY TEST; PRIORITY JOURNAL; PROBABILITY; RACE DIFFERENCE; SMOKING; UNITED STATES; URINALYSIS; URINE LEVEL; BLOOD; INFERTILITY, FEMALE; PHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; TIME TO PREGNANCY; URINE;

ADULT; ANTI-MULLERIAN HORMONE; BIOMARKERS; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; INFERTILITY, FEMALE; INHIBINS; OVARIAN RESERVE; PREGNANCY; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; TIME-TO-PREGNANCY;

EID: 85031330976     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2017.14588     Document Type: Article

References (27)

1. Mathews TJ, Hamilton BE. Mean age of mothers is on the rise: United States, 2000-2014. NCHS Data Brief. 2016;(232):1-8.
2. Hansen KR, Knowlton NS, Thyer AC, Charleston JS, Soules MR, Klein NA. A new model of reproductive aging: the decline in ovarian non-growing follicle number from birth to menopause. Hum Reprod. 2008;23(3):699-708.
3. Lee MM, Donahoe PK. Müllerian inhibiting substance: a gonadal hormone with multiple functions. Endocr Rev. 1993;14(2):152-164.
4. Roberts VJ, Barth S, el-Roeiy A, Yen SS. Expression of inhibin/activin subunits and follistatin messenger ribonucleic acids and proteins in ovarian follicles and the corpus luteum during the human menstrual cycle. J Clin Endocrinol Metab. 1993;77 (5):1402-1410.
5. Santoro N, Isaac B, Neal-Perry G, et al. Impaired folliculogenesis and ovulation in older reproductive aged women. J Clin Endocrinol Metab. 2003;88 (11):5502-5509.
6. Freeman EW, Sammel MD, Lin H, Boorman DW, Gracia CR. Contribution of the rate of change of antimüllerian hormone in estimating time to menopause for late reproductive-age women. Fertil Steril. 2012;98(5):1254-1259.
7. Dólleman M, Faddy MJ, van Disseldorp J, et al. The relationship between anti-Müllerian hormone in women receiving fertility assessments and age at menopause in subfertile women: evidence from large population studies. J Clin Endocrinol Metab. 2013;98(5):1946-1953.
8. Wu CH, Chen YC, Wu HH, Yang JG, Chang YJ, Tsai HD. Serum anti-Müllerian hormone predicts ovarian response and cycle outcome in IVF patients. J Assist Reprod Genet. 2009;26(7):383-389.
9. Broer SL, van Disseldorp J, Broeze KA, et al; IMPORT Study Group. Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach. Hum Reprod Update. 2013;19(1):26-36.
10. Broer SL, Mol BW, Hendriks D, Broekmans FJ. The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count. Fertil Steril. 2009;91(3):705-714.
11. Brodin T, Hadziosmanovic N, Berglund L, Olovsson M, Holte J. Antimüllerian hormone levels are strongly associated with live-birth rates after assisted reproduction. J Clin Endocrinol Metab. 2013;98(3):1107-1114.
12. Steiner AZ, Long DL, Herring AH, Kesner JS, Meadows JW, Baird DD. Urinary follicle-stimulating hormone as a measure of natural fertility in a community cohort. Reprod Sci. 2013;20(5):549-556.
13. Steiner AZ, Herring AH, Kesner JS, et al. Antimüllerian hormone as a predictor of natural fecundability in women aged 30-42 years. Obstet Gynecol. 2011;117(4):798-804.
14. Jain T, Soules MR, Collins JA. Comparison of basal follicle-stimulating hormone versus the clomiphene citrate challenge test for ovarian reserve screening. Fertil Steril. 2004;82(1):180-185.
15. Weinberg CR, Wilcox AJ. Reproductive epidemiology. In: Rothman KJ, Greenland S, eds. Modern Epidemiology. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 1998:585-608.
16. Centers for Disease Control and Prevention; Society for Assisted Reproductive Technology. 2014 Assisted Reproductive Technology National Summary Report. Atlanta, GA: US Dept of Health and Human Services; 2016.
17. Centers for Disease Control and Prevention. About adult BMI. https://www.cdc.gov/healthyweight/assessing/bmi/adult_bmi/index.html. Accessed September 1, 2017.
18. Li HW, Wong BP, Ip WK, Yeung WS, Ho PC, Ng EH. Comparative evaluation of three new commercial immunoassays for anti-Müllerian hormone measurement. Hum Reprod. 2016;31(12): 2796-2802.
19. Hagen CP, Vestergaard S, Juul A, et al. Low concentration of circulating antimüllerian hormone is not predictive of reduced fecundability in young healthy women: a prospective cohort study. Fertil Steril. 2012;98(6):1602-1608.
20. Zarek SM, Mitchell EM, Sjaarda LA, et al. Is anti-Müllerian hormone associated with fecundability? findings from the EAGER trial. J Clin Endocrinol Metab. 2015;100(11):4215-4221.
21. Depmann M, Broer SL, Eijkemans MJC, et al. Anti-Müllerian hormone does not predict time to pregnancy: results of a prospective cohort study [published online April 10, 2017]. Gynecol Endocrinol. doi:10.1080/09513590.2017.1306848
22. Benirschke K, Kim CK. Multiple pregnancy, 1. N Engl J Med. 1973;288(24):1276-1284.
23. Pigny P, Gorisse E, Ghulam A, et al. Comparative assessment of five serum antimüllerian hormone assays for the diagnosis of polycystic ovary syndrome. Fertil Steril. 2016;105 (4):1063-1069.
24. Pellatt L, Rice S, Dilaver N, et al. Anti-Müllerian hormone reduces follicle sensitivity to follicle-stimulating hormone in human granulosa cells. Fertil Steril. 2011;96(5):1246-1251.
25. Gnoth C, Godehardt D, Godehardt E, Frank-Herrmann P, Freundl G. Time to pregnancy: results of the German prospective study and impact on the management of infertility. Hum Reprod. 2003;18(9):1959-1966.
26. Grande M, Borobio V, Bennasar M, et al. Role of ovarian reserve markers, antimüllerian hormone and antral follicle count, as aneuploidy markers in ongoing pregnancies and miscarriages. Fertil Steril. 2015;103(5):1221-1227.
27. Zarek SM, Mitchell EM, Sjaarda LA, et al. Antimüllerian hormone and pregnancy loss from the Effects of Aspirin in Gestation and Reproduction Trial. Fertil Steril. 2016;105(4):946-952.